top of page
Digital Network

Strengthening the response to infectious diseases and antimicrobial resistance through precision genomics

The global spread of infectious disease and antimicrobial resistance (AMR) is amongst the greatest risks to the future of humanity.

By 2050, 10 million deaths are predicted annually from antimicrobial-resistant infections alone.

Data driven responses from whole genome sequencing

  • Fully autonomous, interactive genomics platform

  • Optimized for proactive pathogen detection

  • Pinpoints related strains and emerging threats

  • Identifies resistance genes and mutations to track AMR patterns

  • Built to function seamlessly as either a standalone solution or within a network for robust monitoring and collaboration

  • Simple, impactful, and efficient—reducing time, minimizing risk

  • IDEM covers 75 species and growing. This includes all major pathogenic bacteria and Candida auris

By Genpax

Screenshot 2024-04-12 122754.png
IDEM screenshot Oct24.jpg

IDEM increases the utility of pathogen genomics through cutting-edge whole genome insights.

finger print closeup.jpg

Strain identification 

Identification of the specific strain causing infection is crucial for distinguishing between closely related strains that may require different treatments or isolation.

picture of a gene.jpg

Gene detection
 

Pinpoint specific genes and mutations which may influence the response to infections

Hospital Employees_edited.jpg

​​​

​​​

  • Precision insights to contain the transmission of susceptible and resistant strains

  • Enhance resource management and antibiotic stewardship

  • Improve patient safety and outcomes through data-driven responses

Get started today

Find out more about how Genpax is bringing the repsonse to infectious diseases and antimicrobial resistance into the genomic age 

Partners

Solving these global health threats is a collaborative effort. Join IQVIA and our other soon to be announced partners in combating this threat

Latest News

bottom of page